• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改良的顺行静脉-动脉联合心脏停搏液灌注技术与传统顺行方法在冠状动脉旁路移植术中的比较。一项随机临床试验。

Our modified technique of combined antegrade-vein graft cardioplegia infusion versus conventional antegrade method in coronary artery bypass grafting. A randomized clinical trial.

机构信息

Cardiovascular Surgery, Department of Cardiovascular Surgery, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.

Vascular Surgery, Department of Vascular Surgery, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Int J Surg. 2018 Jul;55:53-59. doi: 10.1016/j.ijsu.2018.05.019. Epub 2018 May 18.

DOI:10.1016/j.ijsu.2018.05.019
PMID:29778750
Abstract

BACKGROUND

To determine the efficacy of antegrade cardioplegia supplemented with venous graft perfusion in patients scheduled for coronary artery bypass grafting (CABG).

METHODS

223 consecutive patients scheduled for isolated CABG were randomized to receive either continuous crystalloid cardioplegia via vein grafts on completion of each distal anastomosis plus intermittent blood cardioplegia through aortic root (group 1, n = 110) or antegrade blood cardioplegia alone (group 2, n = 113). Two groups were similar in terms of preoperative patients' and procedural characteristics. The primary end-points were low output syndrome (LOS) variables.

RESULTS

The inotrope and intra-aortic balloon pump demand during weaning were significantly higher in the control group (31.8% vs. 20%, p = 0.043 and 7.9% vs. 1.8%, p = 0.034 respectively). Postoperative level of potassium and arterial base excess (BE), stood in the normal range in both groups, despite significant inter-group differences. Peak serum level of myocardial injury biomarkers (CK, CK-MB, and cTnI) at 12 h following operation, though markedly greater in the group 2, did not reach the cut-off point of myocardial necrosis. Postoperative arrhythmia was more commonly encountered in the control group (p = 0.045). The duration of ventilation and hospital stay were considerably longer in the group 2. In a subgroup with LVEF<30%, the length of ICU stay was more prolonged in the control group, as well (p = 0.0145). The significant differences among groups regarding LOS parameters were more remarkable in the two high-risk subgroups (LVEF<30%, left main coronary stenosis).

CONCLUSIONS

Given the better postoperative cardiac performance, we recommend this method to all CABG candidates, particularly in higher-risk patients.

摘要

背景

为了确定在冠状动脉旁路移植术(CABG)患者中,前向心脏停搏液联合静脉移植物灌注的疗效。

方法

223 例连续接受单纯 CABG 的患者被随机分为两组,每组 113 例:一组在完成每一个远端吻合后通过静脉移植物给予持续的晶体心脏停搏液,同时通过主动脉根部给予间断的血心脏停搏液(组 1);另一组仅给予前向血心脏停搏液(组 2)。两组患者的术前患者特征和手术特点相似。主要终点是低心排血量综合征(LOS)变量。

结果

在撤机时,对照组的正性肌力药物和主动脉内球囊反搏的需求明显更高(31.8%比 20%,p=0.043 和 7.9%比 1.8%,p=0.034)。尽管两组间存在显著差异,但两组的术后血钾和动脉碱剩余(BE)水平均在正常范围内。尽管术后 12 小时组 2 的心肌损伤标志物(CK、CK-MB 和 cTnI)的峰值水平明显更高,但未达到心肌坏死的截止点。对照组术后心律失常更为常见(p=0.045)。组 2 的通气和住院时间明显延长。在 LVEF<30%的亚组中,对照组的 ICU 住院时间也更长(p=0.0145)。在 LOS 参数方面,两组间的显著差异在两个高危亚组(LVEF<30%,左主干狭窄)中更为显著。

结论

鉴于术后心脏功能更好,我们建议所有 CABG 患者采用这种方法,尤其是高危患者。

相似文献

1
Our modified technique of combined antegrade-vein graft cardioplegia infusion versus conventional antegrade method in coronary artery bypass grafting. A randomized clinical trial.改良的顺行静脉-动脉联合心脏停搏液灌注技术与传统顺行方法在冠状动脉旁路移植术中的比较。一项随机临床试验。
Int J Surg. 2018 Jul;55:53-59. doi: 10.1016/j.ijsu.2018.05.019. Epub 2018 May 18.
2
Myocardial Protection with multiport antegrade cold blood cardioplegia and continuous controlled warm shot through vein grafts during proximal ends anastomosis in conventional coronary artery bypass graft.在传统冠状动脉搭桥术近端吻合期间,采用多端口顺行冷血心脏停搏液及经静脉移植物持续控制性温灌注进行心肌保护。
J Pak Med Assoc. 2016 Jan;66(1):53-8.
3
Effect of antegrade graft cardioplegia combined with passive graft perfusion in on-pump coronary artery bypass grafting.顺行性移植物心脏停搏联合被动移植物灌注在体外循环冠状动脉旁路移植术中的作用
J Int Med Res. 2010 Jul-Aug;38(4):1333-42. doi: 10.1177/147323001003800415.
4
Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.心脏不停跳下的主动脉瓣和二尖瓣手术正在缩短体外循环和主动脉阻断时间。
Heart Surg Forum. 2002;5(2):182-6.
5
Cardioplegia Application with A Hand-Squeezed Cardioplegia Bag. Is It Safe?手动挤压式心脏停搏袋的心脏停搏液应用:安全吗?
Heart Surg Forum. 2021 Jul 26;24(4):E619-E623. doi: 10.1532/hsf.3933.
6
[Myocardial protection during multiple coronary artery bypass grafting--a comparison of antegrade and combined antegrade-retrograde cardioplegia].[多次冠状动脉搭桥术中的心肌保护——顺行与顺行-逆行联合心脏停搏的比较]
Nihon Kyobu Geka Gakkai Zasshi. 1994 Jul;42(7):997-1002.
7
Antegrade crystalloid cardioplegia vs antegrade/retrograde cold and tepid blood cardioplegia in CABG.冠状动脉旁路移植术中顺行晶体心脏停搏液与顺行/逆行冷和温血心脏停搏液的比较
Ann Thorac Surg. 1999 Aug;68(2):447-53. doi: 10.1016/s0003-4975(99)00359-8.
8
Evaluation of 7,000+ patients with two different routes of cardioplegia.对7000多名患者采用两种不同的心脏停搏途径进行评估。
Ann Thorac Surg. 1997 Jun;63(6):1619-24. doi: 10.1016/s0003-4975(97)00359-7.
9
Comparison of simultaneous antegrade/vein graft cardioplegia with antegrade cardioplegia for myocardial protection.顺行/静脉桥联合心脏停搏液与单纯顺行心脏停搏液心肌保护效果的比较
Adv Ther. 2006 Nov-Dec;23(6):869-77. doi: 10.1007/BF02850208.
10
Cardio-Protective Effects of Multiport Antegrade Cold Blood Cardioplegia Versus Antegrade Cold Blood Cardioplegia in Patients With Left Ventricular Systolic Dysfunction Undergoing Conventional Coronary Artery Bypass Grafting.多端口顺行冷血心脏停搏液与顺行冷血心脏停搏液对接受传统冠状动脉旁路移植术的左心室收缩功能障碍患者的心脏保护作用
Cureus. 2020 Sep 8;12(9):e10308. doi: 10.7759/cureus.10308.

引用本文的文献

1
Selective Vein Graft Cold Cardioplegia and Warm Reperfusion to Enhance Early Recovery in Patients with Left Ventricle Depression Undergoing Coronary Artery Surgery.选择性静脉移植冷心脏停搏液与温血再灌注以促进接受冠状动脉手术的左心室功能不全患者的早期恢复
J Cardiovasc Dev Dis. 2025 Jun 12;12(6):222. doi: 10.3390/jcdd12060222.